Paul Mullan, as GenoME Diagnostics acting CEO, oversaw the completion of their first round of funding for £300k funded by QUBIS (the commercialisation arm of QUB), Clarendon Fund Managers (who manage Co Fund NI), and life science specialist investors Deepbridge Capital. GenoME Diagnostics were the first investment by DBC into Northern Ireland.